Concepts (255)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain | 29 | 2018 | 930 | 1.990 |
Why?
|
Magnetic Resonance Imaging | 32 | 2018 | 1218 | 1.700 |
Why?
|
Image Processing, Computer-Assisted | 11 | 2017 | 242 | 1.030 |
Why?
|
Auditory Perception | 7 | 2009 | 80 | 0.880 |
Why?
|
Brain Mapping | 16 | 2018 | 182 | 0.840 |
Why?
|
Somatosensory Cortex | 2 | 2017 | 26 | 0.840 |
Why?
|
Nerve Net | 9 | 2018 | 115 | 0.760 |
Why?
|
Exercise | 5 | 2018 | 591 | 0.690 |
Why?
|
Beta vulgaris | 2 | 2017 | 11 | 0.660 |
Why?
|
Neuronal Plasticity | 2 | 2017 | 81 | 0.660 |
Why?
|
Cerebral Infarction | 4 | 2008 | 24 | 0.650 |
Why?
|
Visual Perception | 6 | 2009 | 112 | 0.610 |
Why?
|
Visual Cortex | 6 | 2009 | 33 | 0.540 |
Why?
|
Cerebrovascular Circulation | 9 | 2011 | 95 | 0.530 |
Why?
|
Weight Loss | 4 | 2018 | 413 | 0.490 |
Why?
|
Auditory Cortex | 4 | 2009 | 22 | 0.470 |
Why?
|
Humans | 60 | 2019 | 29093 | 0.460 |
Why?
|
Obesity | 6 | 2018 | 1063 | 0.440 |
Why?
|
Cerebral Cortex | 5 | 2009 | 141 | 0.420 |
Why?
|
Adult | 34 | 2018 | 8420 | 0.400 |
Why?
|
Male | 38 | 2018 | 17807 | 0.380 |
Why?
|
Aging | 6 | 2015 | 881 | 0.380 |
Why?
|
Female | 37 | 2018 | 18164 | 0.370 |
Why?
|
Music | 2 | 2007 | 9 | 0.350 |
Why?
|
Career Mobility | 2 | 2019 | 14 | 0.350 |
Why?
|
Acoustic Stimulation | 12 | 2018 | 125 | 0.340 |
Why?
|
Aged | 24 | 2018 | 9487 | 0.340 |
Why?
|
Prefrontal Cortex | 2 | 2013 | 69 | 0.340 |
Why?
|
Attention | 3 | 2009 | 83 | 0.340 |
Why?
|
Radiology | 2 | 2019 | 37 | 0.330 |
Why?
|
Faculty, Medical | 2 | 2019 | 69 | 0.320 |
Why?
|
Perception | 2 | 2012 | 92 | 0.320 |
Why?
|
Neural Inhibition | 1 | 2008 | 27 | 0.320 |
Why?
|
Gyrus Cinguli | 2 | 2008 | 22 | 0.310 |
Why?
|
Magnetic Resonance Angiography | 4 | 2011 | 64 | 0.310 |
Why?
|
Cognition | 4 | 2016 | 526 | 0.310 |
Why?
|
Middle Aged | 26 | 2018 | 10829 | 0.310 |
Why?
|
Spin Labels | 5 | 2011 | 23 | 0.300 |
Why?
|
Auditory Pathways | 2 | 2006 | 9 | 0.300 |
Why?
|
Image Enhancement | 3 | 2009 | 70 | 0.290 |
Why?
|
Dyslexia | 2 | 2005 | 8 | 0.290 |
Why?
|
Tomography, X-Ray | 1 | 2006 | 5 | 0.280 |
Why?
|
Walking | 2 | 2017 | 177 | 0.270 |
Why?
|
Overweight | 2 | 2018 | 256 | 0.270 |
Why?
|
Caffeine | 4 | 2009 | 31 | 0.260 |
Why?
|
Image Interpretation, Computer-Assisted | 5 | 2018 | 113 | 0.260 |
Why?
|
Software | 3 | 2015 | 109 | 0.250 |
Why?
|
Nicotine | 2 | 2017 | 157 | 0.250 |
Why?
|
Nitrates | 2 | 2017 | 25 | 0.250 |
Why?
|
Reference Books, Medical | 1 | 2004 | 2 | 0.240 |
Why?
|
Software Validation | 1 | 2004 | 4 | 0.240 |
Why?
|
Medical Informatics Applications | 1 | 2004 | 4 | 0.240 |
Why?
|
Medical Illustration | 1 | 2004 | 7 | 0.240 |
Why?
|
Pesticides | 2 | 2017 | 189 | 0.240 |
Why?
|
Tomography, Emission-Computed | 1 | 2004 | 25 | 0.240 |
Why?
|
Echo-Planar Imaging | 2 | 2009 | 16 | 0.240 |
Why?
|
Perfusion | 1 | 2004 | 64 | 0.240 |
Why?
|
Occupational Exposure | 2 | 2017 | 224 | 0.240 |
Why?
|
Frontal Lobe | 1 | 2004 | 45 | 0.240 |
Why?
|
Photic Stimulation | 10 | 2009 | 155 | 0.230 |
Why?
|
Data Interpretation, Statistical | 1 | 2003 | 103 | 0.220 |
Why?
|
Internet | 1 | 2004 | 156 | 0.220 |
Why?
|
Reaction Time | 5 | 2006 | 121 | 0.220 |
Why?
|
Resistance Training | 3 | 2018 | 70 | 0.210 |
Why?
|
Tomography, X-Ray Computed | 2 | 2004 | 871 | 0.210 |
Why?
|
Parietal Lobe | 2 | 2013 | 16 | 0.200 |
Why?
|
Education, Medical, Graduate | 2 | 2019 | 116 | 0.200 |
Why?
|
Neural Pathways | 5 | 2017 | 97 | 0.190 |
Why?
|
Oxygen | 5 | 2017 | 139 | 0.190 |
Why?
|
Reproducibility of Results | 5 | 2009 | 726 | 0.170 |
Why?
|
Double-Blind Method | 3 | 2017 | 501 | 0.170 |
Why?
|
Mentors | 1 | 2019 | 29 | 0.170 |
Why?
|
Memory, Short-Term | 2 | 2016 | 59 | 0.160 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2018 | 43 | 0.160 |
Why?
|
Body Composition | 2 | 2017 | 365 | 0.160 |
Why?
|
Dietary Supplements | 2 | 2017 | 170 | 0.160 |
Why?
|
Pain | 2 | 2011 | 282 | 0.150 |
Why?
|
Military Personnel | 1 | 2018 | 85 | 0.150 |
Why?
|
Imaging, Three-Dimensional | 3 | 2009 | 130 | 0.150 |
Why?
|
Quality of Life | 3 | 2017 | 816 | 0.140 |
Why?
|
Cerebrovascular Disorders | 2 | 2009 | 48 | 0.140 |
Why?
|
Disability Evaluation | 1 | 2017 | 211 | 0.140 |
Why?
|
Psychomotor Performance | 3 | 2005 | 97 | 0.140 |
Why?
|
Cerebellum | 2 | 2013 | 29 | 0.140 |
Why?
|
Nitrites | 2 | 2017 | 20 | 0.140 |
Why?
|
Central Nervous System Stimulants | 2 | 2009 | 74 | 0.140 |
Why?
|
Nonlinear Dynamics | 1 | 2014 | 52 | 0.130 |
Why?
|
Gambling | 1 | 2014 | 6 | 0.120 |
Why?
|
Emigrants and Immigrants | 1 | 2017 | 235 | 0.120 |
Why?
|
Functional Laterality | 3 | 2011 | 59 | 0.120 |
Why?
|
Alcohol Drinking | 1 | 2016 | 244 | 0.120 |
Why?
|
Brain Injuries | 2 | 2011 | 94 | 0.120 |
Why?
|
Thalamus | 1 | 2013 | 39 | 0.120 |
Why?
|
Analysis of Variance | 6 | 2011 | 454 | 0.120 |
Why?
|
Hispanic Americans | 2 | 2017 | 904 | 0.110 |
Why?
|
Choice Behavior | 1 | 2014 | 83 | 0.110 |
Why?
|
Geriatric Assessment | 1 | 2015 | 355 | 0.110 |
Why?
|
Motor Activity | 1 | 2015 | 310 | 0.110 |
Why?
|
Risk Reduction Behavior | 1 | 2013 | 116 | 0.110 |
Why?
|
Mobility Limitation | 1 | 2014 | 187 | 0.110 |
Why?
|
Aged, 80 and over | 7 | 2016 | 3717 | 0.110 |
Why?
|
Social Control, Informal | 1 | 2012 | 7 | 0.110 |
Why?
|
Appetite | 1 | 2012 | 19 | 0.110 |
Why?
|
Decision Making | 1 | 2014 | 180 | 0.100 |
Why?
|
Food Preferences | 1 | 2012 | 35 | 0.100 |
Why?
|
Heart Failure | 1 | 2017 | 568 | 0.100 |
Why?
|
Putamen | 1 | 2011 | 25 | 0.100 |
Why?
|
Diet | 2 | 2012 | 354 | 0.100 |
Why?
|
Holistic Health | 1 | 2011 | 6 | 0.100 |
Why?
|
Therapeutic Touch | 1 | 2011 | 10 | 0.100 |
Why?
|
Young Adult | 6 | 2015 | 2402 | 0.100 |
Why?
|
Comprehension | 1 | 2011 | 19 | 0.100 |
Why?
|
Intracranial Arteriovenous Malformations | 1 | 2011 | 18 | 0.100 |
Why?
|
Pruritus | 1 | 2011 | 58 | 0.090 |
Why?
|
Cues | 3 | 2006 | 67 | 0.090 |
Why?
|
Hypertension | 1 | 2017 | 906 | 0.090 |
Why?
|
Neuropsychological Tests | 4 | 2015 | 379 | 0.090 |
Why?
|
Diagnosis, Differential | 3 | 2008 | 493 | 0.090 |
Why?
|
Perfusion Imaging | 1 | 2009 | 7 | 0.090 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2009 | 33 | 0.090 |
Why?
|
Database Management Systems | 1 | 2009 | 11 | 0.090 |
Why?
|
Perceptual Disorders | 1 | 2009 | 7 | 0.090 |
Why?
|
Information Storage and Retrieval | 1 | 2009 | 24 | 0.090 |
Why?
|
Brain Diseases | 1 | 2009 | 40 | 0.080 |
Why?
|
Models, Neurological | 2 | 2014 | 115 | 0.080 |
Why?
|
Regression Analysis | 3 | 2017 | 274 | 0.080 |
Why?
|
Epilepsy, Tonic-Clonic | 1 | 2008 | 9 | 0.080 |
Why?
|
Cerebral Arteries | 1 | 2008 | 18 | 0.080 |
Why?
|
Models, Biological | 1 | 2010 | 373 | 0.080 |
Why?
|
Neurologic Examination | 2 | 2011 | 28 | 0.080 |
Why?
|
Retrospective Studies | 5 | 2017 | 3111 | 0.080 |
Why?
|
Hemiplegia | 1 | 2007 | 12 | 0.080 |
Why?
|
Arm | 1 | 2007 | 31 | 0.080 |
Why?
|
Radiosurgery | 1 | 2011 | 322 | 0.080 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2007 | 31 | 0.080 |
Why?
|
Hand | 1 | 2007 | 63 | 0.070 |
Why?
|
Contrast Media | 2 | 2009 | 123 | 0.070 |
Why?
|
Coffee | 2 | 2003 | 10 | 0.070 |
Why?
|
Rest | 2 | 2017 | 49 | 0.070 |
Why?
|
Cotinine | 2 | 2017 | 45 | 0.070 |
Why?
|
Time Perception | 1 | 2006 | 6 | 0.070 |
Why?
|
Judgment | 1 | 2006 | 11 | 0.070 |
Why?
|
Pitch Discrimination | 1 | 2005 | 1 | 0.070 |
Why?
|
Cardiovascular Diseases | 1 | 2013 | 1013 | 0.070 |
Why?
|
Diffusion | 2 | 2002 | 12 | 0.070 |
Why?
|
Sensitivity and Specificity | 2 | 2009 | 532 | 0.070 |
Why?
|
Ischemic Attack, Transient | 1 | 2006 | 46 | 0.070 |
Why?
|
Discrimination Learning | 1 | 2005 | 20 | 0.070 |
Why?
|
Single-Blind Method | 3 | 2017 | 165 | 0.070 |
Why?
|
Internship and Residency | 2 | 2019 | 283 | 0.070 |
Why?
|
Muscle Strength | 2 | 2017 | 139 | 0.060 |
Why?
|
Time Factors | 3 | 2006 | 2001 | 0.060 |
Why?
|
Adolescent | 5 | 2011 | 3254 | 0.060 |
Why?
|
Probability | 2 | 2017 | 150 | 0.060 |
Why?
|
Blood Volume | 1 | 2004 | 6 | 0.060 |
Why?
|
Evoked Potentials | 1 | 2003 | 16 | 0.060 |
Why?
|
Sound Localization | 1 | 2003 | 6 | 0.060 |
Why?
|
Myopia | 1 | 2003 | 5 | 0.060 |
Why?
|
Arousal | 1 | 2003 | 19 | 0.060 |
Why?
|
Terminology as Topic | 1 | 2004 | 62 | 0.060 |
Why?
|
Stroke | 1 | 2009 | 545 | 0.060 |
Why?
|
Case-Control Studies | 1 | 2005 | 859 | 0.060 |
Why?
|
Brain Edema | 1 | 2003 | 16 | 0.060 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2003 | 24 | 0.060 |
Why?
|
Cluster Analysis | 2 | 2014 | 128 | 0.060 |
Why?
|
Age Factors | 3 | 2014 | 1108 | 0.060 |
Why?
|
Psychophysiology | 1 | 2002 | 2 | 0.060 |
Why?
|
Oxygen Consumption | 1 | 2003 | 138 | 0.060 |
Why?
|
Gadolinium DTPA | 1 | 2002 | 13 | 0.050 |
Why?
|
Dominance, Cerebral | 1 | 2002 | 11 | 0.050 |
Why?
|
Hearing | 1 | 2002 | 11 | 0.050 |
Why?
|
Corpus Callosum | 1 | 2002 | 13 | 0.050 |
Why?
|
Language | 1 | 2002 | 44 | 0.050 |
Why?
|
Research Design | 1 | 2004 | 286 | 0.050 |
Why?
|
Acute Disease | 1 | 2002 | 239 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2006 | 587 | 0.050 |
Why?
|
Blood Flow Velocity | 2 | 2011 | 59 | 0.050 |
Why?
|
Pain Threshold | 2 | 2011 | 95 | 0.050 |
Why?
|
Organizational Objectives | 1 | 2019 | 22 | 0.040 |
Why?
|
Pain Measurement | 2 | 2011 | 364 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2017 | 2108 | 0.040 |
Why?
|
Statistics as Topic | 2 | 2009 | 106 | 0.040 |
Why?
|
Regional Blood Flow | 2 | 2010 | 82 | 0.040 |
Why?
|
Acetylcholinesterase | 1 | 2017 | 17 | 0.040 |
Why?
|
Sensory Thresholds | 2 | 2009 | 26 | 0.040 |
Why?
|
Diet, Reducing | 1 | 2018 | 90 | 0.040 |
Why?
|
Butyrylcholinesterase | 1 | 2017 | 15 | 0.040 |
Why?
|
Child | 3 | 2011 | 2219 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2016 | 3099 | 0.040 |
Why?
|
Physical Endurance | 1 | 2017 | 31 | 0.040 |
Why?
|
Cohort Studies | 2 | 2015 | 1687 | 0.040 |
Why?
|
ROC Curve | 1 | 2016 | 149 | 0.040 |
Why?
|
Cholinesterases | 1 | 2016 | 10 | 0.040 |
Why?
|
Models, Statistical | 1 | 2017 | 163 | 0.040 |
Why?
|
Behavior Therapy | 1 | 2016 | 89 | 0.030 |
Why?
|
Exercise Therapy | 1 | 2018 | 229 | 0.030 |
Why?
|
Psychometrics | 1 | 2015 | 129 | 0.030 |
Why?
|
Information Theory | 1 | 2014 | 3 | 0.030 |
Why?
|
Stroke Volume | 1 | 2017 | 278 | 0.030 |
Why?
|
Agriculture | 1 | 2016 | 174 | 0.030 |
Why?
|
Life Style | 1 | 2016 | 364 | 0.030 |
Why?
|
Behavior | 1 | 2013 | 29 | 0.030 |
Why?
|
Personal Satisfaction | 1 | 2013 | 25 | 0.030 |
Why?
|
Task Performance and Analysis | 1 | 2013 | 51 | 0.030 |
Why?
|
Reward | 1 | 2014 | 63 | 0.030 |
Why?
|
Infant | 2 | 2009 | 969 | 0.030 |
Why?
|
Transients and Migrants | 1 | 2016 | 281 | 0.030 |
Why?
|
Blood Pressure | 1 | 2017 | 804 | 0.030 |
Why?
|
Child, Preschool | 2 | 2009 | 1167 | 0.030 |
Why?
|
Reference Values | 2 | 2003 | 224 | 0.030 |
Why?
|
Drive | 1 | 2012 | 2 | 0.030 |
Why?
|
Postprandial Period | 1 | 2012 | 10 | 0.030 |
Why?
|
Taste | 1 | 2012 | 15 | 0.030 |
Why?
|
Water | 1 | 2012 | 50 | 0.030 |
Why?
|
Bone Density | 1 | 2013 | 182 | 0.030 |
Why?
|
Behavior, Addictive | 1 | 2012 | 29 | 0.030 |
Why?
|
North Carolina | 1 | 2016 | 1423 | 0.030 |
Why?
|
Caenorhabditis elegans | 1 | 2011 | 19 | 0.030 |
Why?
|
Psychoacoustics | 1 | 2011 | 2 | 0.030 |
Why?
|
Self Efficacy | 1 | 2012 | 70 | 0.030 |
Why?
|
Energy Intake | 1 | 2012 | 120 | 0.030 |
Why?
|
Afferent Pathways | 1 | 2011 | 23 | 0.030 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2011 | 53 | 0.020 |
Why?
|
Random Allocation | 1 | 2011 | 213 | 0.020 |
Why?
|
Mental Processes | 1 | 2010 | 17 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2012 | 159 | 0.020 |
Why?
|
Hyperalgesia | 1 | 2011 | 88 | 0.020 |
Why?
|
Databases, Factual | 1 | 2011 | 332 | 0.020 |
Why?
|
Risk Factors | 1 | 2017 | 3531 | 0.020 |
Why?
|
Saliva | 1 | 2009 | 36 | 0.020 |
Why?
|
Animals | 2 | 2011 | 7297 | 0.020 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2009 | 11 | 0.020 |
Why?
|
Administration, Oral | 1 | 2009 | 169 | 0.020 |
Why?
|
Arteries | 1 | 2009 | 60 | 0.020 |
Why?
|
Hot Temperature | 1 | 2009 | 71 | 0.020 |
Why?
|
Motor Skills | 1 | 2007 | 12 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 641 | 0.020 |
Why?
|
Brain Ischemia | 1 | 2009 | 136 | 0.020 |
Why?
|
Movement | 1 | 2007 | 41 | 0.020 |
Why?
|
Fingers | 1 | 2007 | 57 | 0.020 |
Why?
|
Algorithms | 1 | 2010 | 462 | 0.020 |
Why?
|
Organ Size | 1 | 2007 | 196 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2008 | 176 | 0.020 |
Why?
|
Visual Pathways | 1 | 2006 | 29 | 0.020 |
Why?
|
Recovery of Function | 1 | 2007 | 190 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2005 | 51 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2008 | 366 | 0.020 |
Why?
|
Cerebral Ventriculography | 1 | 2003 | 3 | 0.010 |
Why?
|
Subarachnoid Space | 1 | 2003 | 5 | 0.010 |
Why?
|
Intracranial Pressure | 1 | 2003 | 19 | 0.010 |
Why?
|
Fixation, Ocular | 1 | 2002 | 5 | 0.010 |
Why?
|
Linear Models | 1 | 2003 | 426 | 0.010 |
Why?
|
Acetazolamide | 1 | 2002 | 1 | 0.010 |
Why?
|
Anisotropy | 1 | 2002 | 10 | 0.010 |
Why?
|
Cadaver | 1 | 2002 | 143 | 0.010 |
Why?
|